We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1378:HKEXChina Hongqiao Group Limited Analysis

Data as of 2026-06-11 - not real-time

HK$26.36

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

China Hongqiao (1378.HK) is trading at HK$26.36, just below its DCF fair value of HK$26.79, suggesting a modest undervaluation. The stock’s trailing P/E of 9.55 and a dividend yield of 6.21% provide a compelling value proposition, especially given a payout ratio of only 39% and robust free cash flow of HK$21.13 bn.
Technical signals show the shares are in oversold territory with an RSI of 29.7 and a bearish MACD histogram, while price sits just above a key support level of HK$24.88 and volume is trending upward, indicating potential short‑term buying interest despite a neutral trend.
Fundamentally, the company maintains solid profitability (operating margin 21.9%, ROE 18.6%) and a manageable debt‑to‑equity of 51%, but revenue has slipped 1.5% year‑over‑year, reflecting cyclical pressures in the aluminum sector. High 30‑day volatility (43%) and a beta below 1 imply price swings but limited systematic risk, while the concentration in China adds moderate geographic and regulatory exposure. Overall, the blend of attractive yield, near‑fair valuation, and improving technical momentum supports a bullish outlook, particularly for investors with a longer horizon.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • RSI indicating oversold conditions
  • Price above immediate support level
  • Increasing trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable cash flow and dividend yield
  • Valuation near DCF fair value
  • Cyclical sector exposure

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive dividend sustainability
  • Strong ROE and cash generation
  • Potential upside to analyst median target (~HK$45)

Key Metrics & Analysis

Financial Health

Revenue Growth-1.50%
Profit Margin13.94%
P/E Ratio9.6
ROE18.56%
ROA9.42%
Debt/Equity51.18
P/B Ratio1.7
Op. Cash FlowHK$39.0B
Free Cash FlowHK$21.1B

Technical Analysis

TrendNeutral
RSI29.7
SupportHK$24.88
ResistanceHK$34.66
MA 20HK$29.18
MA 50HK$33.08
MA 200HK$31.81
MACDBearish
VolumeIncreasing
Fear & Greed Index81.75

Valuation

Fair ValueHK$26.79
Target PriceHK$44.62
Upside/Downside69.29%
GradeUndervalued
TypeValue
Dividend Yield6.21%

Risk Assessment

Beta0.89
Volatility43.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.